Schedule 13D ownership disclosure

ADURO BIOTECH, INC.

Security class unavailable · CUSIP: 00739L101

Event date: 2015-04-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
19,805,532
Percent of class
32.5600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-030143
Form type
SC 13D
Filer
CHINOOK THERAPEUTICS, INC.
CIK
CIK 1435049
Filed
Apr 24, 2015
Reporting period
Apr 14, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub